Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Long-Term Investments (2024 - 2025)

Praxis Precision Medicines (PRAX) has 2 years of Long-Term Investments data on record, last reported at $326.8 million in Q4 2025.

  • For Q4 2025, Long-Term Investments rose 324.57% year-over-year to $326.8 million; the TTM value through Dec 2025 reached $326.8 million, up 324.57%, while the annual FY2025 figure was $326.8 million, 324.57% up from the prior year.
  • Long-Term Investments reached $326.8 million in Q4 2025 per PRAX's latest filing, up from $122.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $326.8 million in Q4 2025 and bottomed at $35.9 million in Q1 2024.